Peritoneal Flap in Robot-Assisted Radical Prostatectomy

被引:28
作者
Bruendl, Johannes [1 ]
Lenart, Sebastian [2 ,3 ]
Stojanoski, Gjoko [4 ]
Gilfrich, Christian [4 ]
Rosenhammer, Bernd [1 ]
Stolzlechner, Michael [2 ]
Ponholzer, Anton [2 ]
Dreissig, Christina [5 ]
Weikert, Steffen [5 ]
Burger, Maximilian [1 ]
May, Matthias [4 ]
机构
[1] Univ Regensburg, Dept Urol, Caritas St Josef Med Ctr, Regensburg, Germany
[2] Hosp St John God, Dept Urol & Androl, Krankenhaus Barmherzigen Bruder Wien, Vienna, Austria
[3] Paracelsus Med Univ Salzburg, Dept Urol & Androl, Salzburg, Austria
[4] St Elisabeth Hosp Straubing, Dept Urol, Straubing, Germany
[5] Vivantes Humboldt Hosp Berlin, Dept Urol, Berlin, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2020年 / 117卷 / 14期
关键词
LYMPH-NODE DISSECTION; PELVIC LYMPHADENECTOMY; SYMPTOMATIC LYMPHOCELE; COMPLICATIONS; OUTCOMES; EXTRAPERITONEAL; CANCER; GUIDELINES; THERAPY;
D O I
10.3238/arztebl.2020.0243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Lymphocele is the most common complication arising after pelvic lymph node dissection (PLND) in the setting of robot-assisted radical prostatectomy (RARP). The only data available until now on the utility of a peritoneal flap to prevent lymphocele were retrospectively acquired. Methods: A randomized, controlled, multi-center trial with blinded assessment of endpoints was carried out on 232 patients with prostate cancer who underwent RARP with PLND. The patients in the intervention group were given a peritoneal flap; in the control group, surgery was performed without this modification. The two joint primary endpoints were the rates of symptomatic lymphocele during the same hospitalization as the operative procedure (iT1) and within 90 days of surgery (iT2). The secondary endpoints were lymphocele volume, the need for treatment of lymphocele, complications requiring an intervention, and the degree of postoperative stress incontinence. German Clinical Trials Register number: DRKS00011115. Results: The data were evaluated in an intention-to-treat analysis, which, in this trial, was identical to an as-treated analysis. 108 patients (46.6%) were allotted to the intervention group. There were no statistically significant intergroup differences with respect to any clinical or histopathological criteria. A median of 16 lymph nodes were removed (interquartile range, 11-21). A symptomatic lymphocele arose in 1.3% (iT1) and 9.1% (iT2) of the patients, without any statistically significant difference between the two trial groups (p = 0.599 and p = 0.820, respectively). Nor did the groups differ significantly with respect to lymphocele volume (p = 0.670 on hospital discharge [T1], p = 0.650 90 days after surgery [T2]) or the type and frequency of need for subsequent surgical intervention (p = 0.535; iT2). 81.5% of all patients (n = 189) had no complications at all in the first three months after surgery. Nor were there any intergroup differences at 90 days with respect to the degree of stress urinary incontinence (p = 0.306) or complications (p = 0.486). Conclusion: A peritoneal flap after RARP was not found to influence the rate of postoperative lymphocele, whether asymptomatic or requiring treatment.
引用
收藏
页码:243 / +
页数:10
相关论文
共 36 条
  • [1] Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner?
    Basiri, Abbas
    de la Rosette, Jean J. M. C. H.
    Tabatabaei, Shahin
    Woo, Henry H.
    Laguna, M. Pilar
    Shemshaki, Hamidreza
    [J]. WORLD JOURNAL OF UROLOGY, 2018, 36 (04) : 609 - 621
  • [2] Radiotherapy and Hormone Treatment in Prostate Cancer The Use of Combined External Beam Radiotherapy and Hormonal Therapy in the Management of Localized and Locally Advanced Prostate Cancer
    Boehmer, Dirk
    Wirth, Manfred
    Miller, Kurt
    Budach, Volker
    Heidenreich, Axel
    Wiegel, Thomas
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2016, 113 (14): : 235 - +
  • [3] Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer
    Briganti, Alberto
    Chun, Felix K. -H.
    Salonia, Andrea
    Suardi, Nazareno
    Gallina, Andrea
    Da Pozzo, Luigi Filippo
    Roscigno, Marco
    Zanni, Giuseppe
    Valiquette, Luc
    Rigatti, Patrizio
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    [J]. EUROPEAN UROLOGY, 2006, 50 (05) : 1006 - 1013
  • [4] Pelvic Lymph Node Dissection in Prostate Cancer
    Briganti, Alberto
    Blute, Michael L.
    Eastham, James H.
    Graefen, Markus
    Heidenreich, Axel
    Karnes, Jeffrey R.
    Montorsi, Francesco
    Studer, Urs E.
    [J]. EUROPEAN UROLOGY, 2009, 55 (06) : 1251 - 1265
  • [5] Prospective Randomized Controlled Trial Exploring the Effect of TachoSil on Lymphocele Formation After Extended Pelvic Lymph Node Dissection in Prostate Cancer
    Buelens, Sarah
    Van Praet, Charles
    Poelaert, Filip
    Van Huele, Andries
    Decaestecker, Karel
    Lumen, Nicolaas
    [J]. UROLOGY, 2018, 118 : 134 - 140
  • [6] Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Blank, K
    Broderick, GA
    Tomaszewski, JE
    Renshaw, AA
    Kaplan, I
    Beard, CJ
    Wein, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11): : 969 - 974
  • [7] Deutsches Register Klinischer Studien (DRKS), STUD
  • [8] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [9] The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review
    Fossati, Nicola
    Willemse, Peter-Paul M.
    Van den Broeck, Thomas
    van den Bergh, Roderick C. N.
    Yuan, Cathy Yuhong
    Briers, Erik
    Bellmunt, Joaquim
    Bolla, Michel
    Cornford, Philip
    De Santis, Maria
    MacPepple, Ekelechi
    Henry, Ann M.
    Mason, Malcolm D.
    Matveev, Vsevolod B.
    van der Poel, Henk G.
    van der Kwast, Theo H.
    Rouviere, Olivier
    Schoots, Ivo G.
    Wiegel, Thomas
    Lam, Thomas B.
    Mottet, Nicolas
    Joniau, Steven
    [J]. EUROPEAN UROLOGY, 2017, 72 (01) : 84 - 109
  • [10] Gesellschaft der epidemiologischen Krebsregister e. V. (GEKID) und Zentrum fur Krebsregisterdaten (ZfKD), 2017, KREBS DEUTSCHL 2015